Viewing Study NCT00170456


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-05 @ 3:11 AM
Study NCT ID: NCT00170456
Status: COMPLETED
Last Update Posted: 2008-09-15
First Post: 2005-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Range and Schedule of rPA Doses
Sponsor: PharmAthene UK Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prevention of Bacillus Anthracis (Anthrax) Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anthrax vaccine View